Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94319702 | 9431970 | 2 | F | 20130701 | 20130806 | 20130731 | 20130816 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-19105550 | BRISTOL MYERS SQUIBB | 58.00 | YR | F | Y | 47.40000 | KG | 20130816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94319702 | 9431970 | 1 | PS | IPILIMUMAB | 1 | INTRAVENOUS | LAST DOSE:13JUN2013 490MG.?IND 1:494MG ON 11APR13,IND 2:480MG ON 2MAY13,IND 3:496MG ON 23MAY13. | D | 0 | 10 | MG/KG | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94319702 | 9431970 | 1 | Malignant melanoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94319702 | 9431970 | OT |
| 94319702 | 9431970 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94319702 | 9431970 | Colitis | |
| 94319702 | 9431970 | Hypokalaemia | |
| 94319702 | 9431970 | Rash maculo-papular |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94319702 | 9431970 | 1 | 20130411 | 0 |